Compared to Estimates, Intuitive Surgical (ISRG) Q3 Earnings: A Look at Key Metrics

19.10.24 01:30 Uhr

Werte in diesem Artikel
Aktien

507,80 EUR 2,10 EUR 0,42%

Indizes

PKT PKT

20.684,6 PKT 145,4 PKT 0,71%

18.987,5 PKT 195,7 PKT 1,04%

5.917,0 PKT 23,4 PKT 0,40%

For the quarter ended September 2024, Intuitive Surgical, Inc. (ISRG) reported revenue of $2.04 billion, up 16.9% over the same period last year. EPS came in at $1.84, compared to $1.46 in the year-ago quarter.The reported revenue represents a surprise of +1.17% over the Zacks Consensus Estimate of $2.01 billion. With the consensus EPS estimate being $1.65, the EPS surprise was +11.52%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Intuitive Surgical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Total System Units Placed - Total Company: 379 versus 316 estimated by five analysts on average. Da Vinci Surgical System Installed Base: 9,539 versus 9,498 estimated by four analysts on average. Total System Units Placed - United States: 219 versus 160 estimated by two analysts on average. Revenue- Product (Instruments and accessories and Systems): $1.71 billion versus $1.66 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +17.8% change. Revenue- Services: $328.90 million compared to the $332.31 million average estimate based on seven analysts. The reported number represents a change of +12.3% year over year. Revenue- Systems: $445 million versus $417.75 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +17.3% change. Revenue- Instruments and accessories: $1.26 billion compared to the $1.24 billion average estimate based on seven analysts. The reported number represents a change of +18% year over year. Gross profit- Service: $220.10 million versus $225.36 million estimated by two analysts on average. Gross profit- Product: $1.15 billion versus the two-analyst average estimate of $1.10 billion. View all Key Company Metrics for Intuitive Surgical here>>>Shares of Intuitive Surgical have returned -3.3% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.7% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Intuitive Surgical

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Intuitive Surgical Inc

Analysen zu Intuitive Surgical Inc

DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
26.01.2018Intuitive Surgical HoldCanaccord Adams
18.07.2017Intuitive Surgical Sector PerformRBC Capital Markets
30.06.2017Intuitive Surgical NeutralCantor Fitzgerald
30.05.2017Intuitive Surgical HoldCanaccord Adams
17.04.2017Intuitive Surgical Sector PerformRBC Capital Markets
DatumRatingAnalyst
23.01.2015Intuitive Surgical SellCRT Capital
22.10.2014Intuitive Surgical SellCRT Capital
09.01.2009Intuitive Surgical DowngradeBrean Murray, Carret & Co., LLC
26.08.2005Update Intuitive Surgical Inc. : UnderperformJefferies & Co

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"